Everolimus | 合法醫療器材資訊網

Lower level of late loss achieved in the LEADERS trial with the BioMatrix Flex™ (​Biolimus A9™) eluting stent at 9 months compared to the Cypher® Select™ ... Read More

Umirolimus (INN/USAN, also called Biolimus) is an immunosuppressant, a macrocyclic lactone, a highly lipophilic derivative of sirolimus. This drug is proprietary ... Read More

由 GJ Vlachojannis 著作 · 2017 · 被引用 12 次 — Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus ... Read More

由 M Maeng 著作 · 2019 · 被引用 14 次 — ... BES with respect to target lesion failure. (Everolimus-eluting SYNERGY Stent Versus Biolimus-Eluting Biomatrix NeoFlex Stent-SORT-OUT VIII; NCT02093845​). Read More

由 E Grube 著作 · 2006 · 被引用 122 次 — Biolimus A9 possesses enhanced anti-inflammatory and antiproliferative activity with an improved pharmacokinetic profile. Permanent polymer-carrier-based ... Read More

由 GJ Vlachojannis 著作 · 2017 · 被引用 66 次 — Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report ... Read More

由 RA Costa 著作 · 2016 · 被引用 55 次 — Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical ... Read More

由 KH Park 著作 · 2018 — Biolimus A9 has a higher lipophilicity and an improved anti-proliferative and anti-​inflammatory activity with an enhanced pharmacokinetic profile. Read More

由 A Seth 著作 · 2013 · 被引用 4 次 — BioMatrix™-Biolimus A9™ eluting stent (BA9™) (BioMatrix) is a new generation DES incorporating a biodegradable polymer containing the anti-proliferative drug​ ... Read More

2020年5月21日 — Background: In patients with increased bleeding risk, the biolimus A9-coated BioFreedom stent, a stainless steel drug-coated stent free from ... Read More